omeprazole has been researched along with leptin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, T; Dojo, M; Ito, Y; Kato, T; Kuriyama, M; Ohtani, M; Suto, H | 1 |
| Adem, A; Adeyemi, EO; Bastaki, SA; Chandranath, IS; Fahim, M; Hasan, MY | 1 |
| Bielanski, W; Brzozowski, T; Celinski, K; Cichoz-Lach, H; Konturek, PC; Konturek, SJ; Slomka, M | 1 |
| Bahekar, R; Detroja, J; Dhanesha, N; Dhote, V; Gandhi, T; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, K; Patel, V | 1 |
1 trial(s) available for omeprazole and leptin
| Article | Year |
|---|---|
Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastrins; Gastroscopy; Ghrelin; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Leptin; Melatonin; Middle Aged; Omeprazole; Stomach Ulcer; Treatment Outcome; Tryptophan; Wound Healing | 2011 |
3 other study(ies) available for omeprazole and leptin
| Article | Year |
|---|---|
Gastric leptin and Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biomarkers; Biopsy; Body Mass Index; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leptin; Male; Middle Aged; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Stomach Neoplasms | 2001 |
Mechanisms of action of leptin in preventing gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Lansoprazole; Leptin; Nitric Oxide; Omeprazole; Prostaglandin-Endoperoxide Synthases; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer | 2005 |
Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.
Topics: Animals; Anti-Obesity Agents; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Gastrins; Glucagon; Hypoglycemic Agents; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred Strains; Mice, Obese; Obesity; Omeprazole; Peptides; Venoms | 2013 |